-The Hindu The Supreme Court's Interim order defining Aadhaar from subsidies has left the Centre grappling with the future of the Unique Identification programme. It must now provide a clear roadmap to citizens and address their genuine concerns. Unique, universal, ubiquitous: three words that Mr Nandan Nilekani used to describe the ambitions of the UID project. Every person across the population of over 1.2 billion was to be uniquely identified. Every person...

-The Indian Express Rajasthan/ Delhi: Three states where the UPA govt has rolled out direct cash transfers go to polls later this year. On the ground, the scheme has not quite turned out the game-changer the government reckoned it would. A frail Gori Sahaab, 90, instructs his son to pour mustard oil into a tiny diya in his one-room house. He once used a kerosene lamp but has stopped buying that fuel....

-The Economic Times NEW DELHI: Over a third of the slum population in India lives without any basic facility being provided by the state as the slums are not recognized. In the case of some states like Rajasthan, Gujarat and Bihar, the entire slum population of several lakhs remains unrecognized by the state governments. For the first time, the census data on slums identified slum dwellers as the people living in compact...

-The Times of India NEW DELHI: The sight of voluntary organizations generously helping villagers in the wake of the Uttarakhand tragedy was heart warming. But, its flip side has the state government concerned. The NGO dole given to villages has caused heartburn among other hamlets where these voluntary organizations did not reach, largely because the relief by non-state bodies is lavish when compared to the structured help provided by the government. Such...

-The Economic Times The government must explain to the Supreme Court, with scientific evidence, why the pentavalent vaccine, now introduced into the immunisation programme, should not be banned. The vaccine is designed to combat five childhood diseases: diphtheria, pertussis, tetanus, Hepatitis B, pneumonia and meningitis. So far, more than 82,000 doses have been administered and there have been 29 cases of adverse effects after immunisation. After examining the evidence, it is unclear...